201 related articles for article (PubMed ID: 25008344)
41. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
Bailey DG; Dresser GK; Bend JR
Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
Miners JO; Chau N; Rowland A; Burns K; McKinnon RA; Mackenzie PI; Tucker GT; Knights KM; Kichenadasse G
Biochem Pharmacol; 2017 Apr; 129():85-95. PubMed ID: 28065859
[TBL] [Abstract][Full Text] [Related]
43. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
[TBL] [Abstract][Full Text] [Related]
44. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of rat liver UDP-glucuronosyltransferase by silymarin and the metabolite silibinin-glucuronide.
D'Andrea V; Pérez LM; Sánchez Pozzi EJ
Life Sci; 2005 Jun; 77(6):683-92. PubMed ID: 15921999
[TBL] [Abstract][Full Text] [Related]
46. Characterization of hepatic and intestinal glucuronidation of magnolol: application of the relative activity factor approach to decipher the contributions of multiple UDP-glucuronosyltransferase isoforms.
Zhu L; Ge G; Zhang H; Liu H; He G; Liang S; Zhang Y; Fang Z; Dong P; Finel M; Yang L
Drug Metab Dispos; 2012 Mar; 40(3):529-38. PubMed ID: 22180045
[TBL] [Abstract][Full Text] [Related]
47. Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitor.
Omura K; Nakazawa T; Sato T; Iwanaga T; Nagata O
Drug Metab Dispos; 2007 Dec; 35(12):2143-8. PubMed ID: 17761779
[TBL] [Abstract][Full Text] [Related]
48. In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans.
Uchaipichat V
Drug Metab Pharmacokinet; 2018 Feb; 33(1):67-76. PubMed ID: 29241692
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the drug-drug interactions potential of erlotinib and gefitinib via inhibition of UDP-glucuronosyltransferases.
Liu Y; Ramírez J; House L; Ratain MJ
Drug Metab Dispos; 2010 Jan; 38(1):32-9. PubMed ID: 19850672
[TBL] [Abstract][Full Text] [Related]
50. Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes.
Chen A; Zhou X; Cheng Y; Tang S; Liu M; Wang X
Toxicol Lett; 2018 Oct; 295():379-389. PubMed ID: 30036684
[TBL] [Abstract][Full Text] [Related]
51. Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes.
Faisal Z; Mohos V; Fliszár-Nyúl E; Valentová K; Káňová K; Lemli B; Kunsági-Máté S; Poór M
Biomed Pharmacother; 2021 Jun; 138():111459. PubMed ID: 33706132
[TBL] [Abstract][Full Text] [Related]
52. Prioritizing pharmacokinetic drug interaction precipitants in natural products: application to OATP inhibitors in grapefruit juice.
Johnson EJ; Won CS; Köck K; Paine MF
Biopharm Drug Dispos; 2017 Apr; 38(3):251-259. PubMed ID: 28032362
[TBL] [Abstract][Full Text] [Related]
53. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins.
Girennavar B; Jayaprakasha GK; Patil BS
J Food Sci; 2007 Oct; 72(8):C417-21. PubMed ID: 17995595
[TBL] [Abstract][Full Text] [Related]
54. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
Al Saabi A; Allorge D; Sauvage FL; Tournel G; Gaulier JM; Marquet P; Picard N
Drug Metab Dispos; 2013 Mar; 41(3):568-74. PubMed ID: 23230132
[TBL] [Abstract][Full Text] [Related]
55. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
[TBL] [Abstract][Full Text] [Related]
56. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor.
Volak LP; Ghirmai S; Cashman JR; Court MH
Drug Metab Dispos; 2008 Aug; 36(8):1594-605. PubMed ID: 18480186
[TBL] [Abstract][Full Text] [Related]
57. Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by beta-naphthoflavone in comparison with humans.
Bock KW; Bock-Hennig BS; Münzel PA; Brandenburg JO; Köhle CT; Soars MG; Riley RJ; Burchell B; von Richter O; Eichelbaum MF; Swedmark S; Orzechowski A
Biochem Pharmacol; 2002 May; 63(9):1683-90. PubMed ID: 12007571
[TBL] [Abstract][Full Text] [Related]
58. Natural and synthetic inhibitors of UDP-glucuronosyltransferase.
Grancharov K; Naydenova Z; Lozeva S; Golovinsky E
Pharmacol Ther; 2001 Feb; 89(2):171-86. PubMed ID: 11316519
[TBL] [Abstract][Full Text] [Related]
59. Potential of herb-drug / herb interactions between substrates and inhibitors of UGTs derived from herbal medicines.
Liu D; Zhang L; Duan LX; Wu JJ; Hu M; Liu ZQ; Wang CY
Pharmacol Res; 2019 Dec; 150():104510. PubMed ID: 31678209
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
